 17. Patient must have adequate hepatic function as indicated by: serum bilirubin within normal limits, aspartate aminotransferase 1.5 times the upper limit of normal and an alkaline phosphatase 1.2 times the upper limit of normal. Patients with an alkaline phosphatase above normal must have negative bone scans and abdominal CT scans prior to entry onto protocol. 